Consolidated Statements of Changes in Stockholders' Deficiency (Parenthetical) |
12 Months Ended |
|---|---|
|
Dec. 31, 2016
USD ($)
| |
| Statement of Stockholders' Equity [Abstract] | |
| Gross proceeds | $ 1,367,120 |
| Sale of Series C convertible preferred stock, issuance costs | 211,835 |
| Sale of Series C convertible preferred stock, cash | 150,383 |
| Sale of Series C convertible preferred stock, non-cash | 61,452 |
| Issuance of warrants | $ 178,414 |
| X | ||||||||||
- Definition Sale of Series C convertible preferred stock, cash. No definition available.
|
| X | ||||||||||
- Definition Sale of Series C convertible preferred stock, non-cash. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|